CLINICAL_TRIALS
trial_result
· 2020-10-23
Clinical Trial Update: Study to Treat Major Depressive Disorder With a New Medication [Phase 2]
Summary
Phase 2 trial update for a new medication targeting major depressive disorder with symptoms including anhedonia; study completed with posted results.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Snippet
Sponsor: James Murrough | Conditions: Depressive Disorder, Anhedonia | Phase 2 | Status: COMPLETED | Results posted: 2020-10-23